Harvard technology to be commercialized by Vesigen Therapeutics

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.

Caroline Perry • harvard
July 22, 2020 ~10 min

Tags: science-technology harvard-th-chan-school-of-public-health office-of-technology-development quan-lu caroline-perry armms arrdc1-mediated-microvesicles blavatnik-biomedical-accesserator large-molecule-drugs vesigen-therapeutics

E-cigarette flavorings may damage cilia production and function

A new study finds two chemicals commonly used to flavor e-cigarettes may be damaging cilia production and function in the human airway.

Karen Feldscher • harvard
Feb. 1, 2019 ~4 min

Tags:  health-medicine  harvard-th-chan-school-of-public-health  3-pentandione  chronic-obstructive-pulmonary-disease  cilia  diacetyl  e-cigarette  electronic-cigarettes  joseph-allen  quan-lu  scientific-reports

Page 1 of 1